{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:42:22Z","timestamp":1759412542396},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126650","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T17:52:16Z","timestamp":1431625936000},"page":"e0126650","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages"],"prefix":"10.1371","volume":"10","author":[{"given":"Lei","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena Itat\u00ed","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronique","family":"Van den Bossche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenny","family":"Roose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameh A.","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.vaccine.2012.03.019","article-title":"Health and economic impact of the seasonal influenza vaccination programme in England","volume":"30","author":"M Baguelin","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"e64593","DOI":"10.1371\/journal.pone.0064593","article-title":"Estimates of excess medically attended acute respiratory infections in periods of seasonal and pandemic influenza in Germany from 2001\/02 to 2010\/11","volume":"8","author":"MA der Heiden","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"ref3","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","author":"TO Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref4","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","author":"T Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref5","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","author":"T Jefferson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"50","key":"ref6","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1016\/j.vaccine.2013.09.063","article-title":"Cochrane re-arranged: support for policies to vaccinate elderly people against influenza","volume":"31","author":"WE Beyer","year":"2013","journal-title":"Vaccine"},{"issue":"16","key":"ref7","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0264-410X(03)00065-3","article-title":"The global agenda on influenza surveillance and control","volume":"21","author":"K Stohr","year":"2003","journal-title":"Vaccine"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"C Gerdil","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"e1000388","DOI":"10.1371\/journal.pmed.1000388","article-title":"Estimates of pandemic influenza vaccine effectiveness in Europe, 2009\u20132010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study","volume":"8","author":"M Valenciano","year":"2011","journal-title":"PLoS Med"},{"issue":"185","key":"ref10","doi-asserted-by":"crossref","first-page":"185ra68","DOI":"10.1126\/scitranslmed.3006368","article-title":"Synthetic generation of influenza vaccine viruses for rapid response to pandemics","volume":"5","author":"PR Dormitzer","year":"2013","journal-title":"Sci Transl Med"},{"issue":"14","key":"ref11","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1074\/jbc.R500020200","article-title":"The M2 proton channels of influenza A and B viruses","volume":"281","author":"LH Pinto","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2014.01.006","article-title":"A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability","volume":"15","author":"R Beale","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"24","key":"ref13","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1128\/JVI.02148-13","article-title":"Influenza A virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells","volume":"87","author":"OP Zhirnov","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ni.1861","article-title":"Influenza virus activates inflammasomes via its intracellular M2 ion channel","volume":"11","author":"T Ichinohe","year":"2010","journal-title":"Nat Immunol"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.cell.2010.08.029","article-title":"Influenza virus M2 protein mediates ESCRT-independent membrane scission","volume":"142","author":"JS Rossman","year":"2010","journal-title":"Cell"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.chom.2009.09.005","article-title":"Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes","volume":"6","author":"M Gannag\u00e9","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2","volume":"3","author":"J Feng","year":"2006","journal-title":"Virol J"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"M Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/infdis\/jit811","article-title":"Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans","volume":"209","author":"W Zhong","year":"2014","journal-title":"J Infect Dis"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"S Neirynck","year":"1999","journal-title":"Nat Med"},{"issue":"51","key":"ref21","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.vaccine.2008.09.038","article-title":"Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies","volume":"26","author":"M De Filette","year":"2008","journal-title":"Vaccine"},{"issue":"23","key":"ref22","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.vaccine.2011.03.090","article-title":"A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus","volume":"29","author":"DG Eliasson","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.vaccine.2007.12.027","article-title":"CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine","volume":"26","author":"DG Eliasson","year":"2008","journal-title":"Vaccine"},{"issue":"Pt 2","key":"ref24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.027086-0","article-title":"Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective","volume":"92","author":"M De Filette","year":"2011","journal-title":"J Gen Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"316926","DOI":"10.1155\/2013\/316926","article-title":"A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens","volume":"2013","author":"KA Reese","year":"2013","journal-title":"Vet Med Int"},{"issue":"32","key":"ref26","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"CB Turley","year":"2011","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.01.002","article-title":"Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity","volume":"178","author":"BZ Wang","year":"2014","journal-title":"J Control Release"},{"issue":"19\u201320","key":"ref28","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"K Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"e45765","DOI":"10.1371\/journal.pone.0045765","article-title":"Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge","volume":"7","author":"H Hashemi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design","volume":"38","author":"J Bessa","year":"2008","journal-title":"European journal of immunology"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"SM Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"23\u201324","key":"ref32","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"J Fan","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/JVI.56.2.502-511.1985","article-title":"Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA","volume":"56","author":"SL Zebedee","year":"1985","journal-title":"J Virol"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"A Jegerlehner","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"K El Bakkouri","year":"2011","journal-title":"J Immunol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0009-9120(02)00343-0","article-title":"Phage display technology: clinical applications and recent innovations","volume":"35","author":"HM Azzazy","year":"2002","journal-title":"Clin Biochem"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/ijms13045179","article-title":"Filamentous bacteriophage fd as an antigen delivery system in vaccination","volume":"13","author":"A Prisco","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1385\/JMN:24:1:105","article-title":"EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials","volume":"24","author":"V Lavie","year":"2004","journal-title":"J Mol Neurosci"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JAD-2008-15205","article-title":"Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment","volume":"15","author":"B Solomon","year":"2008","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","article-title":"Tricine-SDS-PAGE","volume":"1","author":"H Schagger","year":"2006","journal-title":"Nat Protoc"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e59081","DOI":"10.1371\/journal.pone.0059081","article-title":"M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A","volume":"8","author":"LI Ibanez","year":"2013","journal-title":"PloS one"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"issue":"21","key":"ref43","doi-asserted-by":"crossref","first-page":"11455","DOI":"10.1073\/pnas.97.21.11455","article-title":"Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration","volume":"97","author":"D Frenkel","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/cr960065d","article-title":"Phage Display","volume":"97","author":"GP Smith","year":"1997","journal-title":"Chem Rev"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"NE van Houten","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1358\/dnp.2009.22.2.1334451","article-title":"Pandemic preparedness: toward a universal influenza vaccine","volume":"22","author":"K Roose","year":"2009","journal-title":"Drug news & perspectives"},{"issue":"8","key":"ref47","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"SL Zebedee","year":"1988","journal-title":"Journal of virology"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1073\/pnas.86.3.1061","article-title":"Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein","volume":"86","author":"SL Zebedee","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"D Zharikova","year":"2005","journal-title":"Journal of virology"},{"issue":"17","key":"ref50","doi-asserted-by":"crossref","first-page":"11382","DOI":"10.1074\/jbc.M800650200","article-title":"An influenza A vaccine based on tetrameric ectodomain of matrix protein 2","volume":"283","author":"M De Filette","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00253-005-0270-9","article-title":"Phage display systems and their applications","volume":"70","author":"M Paschke","year":"2006","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jmbi.1996.0378","article-title":"Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage","volume":"260","author":"P Malik","year":"1996","journal-title":"J Mol Biol"},{"issue":"4","key":"ref53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/jmbi.1995.0393","article-title":"Location of filamentous phage minor coat proteins in phage and in infected cells","volume":"250","author":"H Endemann","year":"1995","journal-title":"J Mol Biol"},{"issue":"2\u20133","key":"ref54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.03.003","article-title":"Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge","volume":"93","author":"W Liu","year":"2004","journal-title":"Immunol Lett"},{"issue":"5","key":"ref55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/icb.2010.15","article-title":"A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody","volume":"88","author":"D Pejoski","year":"2010","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"ref56","doi-asserted-by":"crossref","first-page":"e5538","DOI":"10.1371\/journal.pone.0005538","article-title":"Vaccination against human influenza A\/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A\/H5N1 virus","volume":"4","author":"R Bodewes","year":"2009","journal-title":"PLoS One"},{"issue":"7","key":"ref57","doi-asserted-by":"crossref","first-page":"e41169","DOI":"10.1371\/journal.pone.0041169","article-title":"Global transcriptome analysis in influenza-infected mouse lungs reveals the kinetics of innate and adaptive host immune responses","volume":"7","author":"C Pommerenke","year":"2012","journal-title":"PloS one"},{"issue":"1","key":"ref58","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JVI.01141-13","article-title":"A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2","volume":"88","author":"PL Herve","year":"2014","journal-title":"Journal of virology"},{"issue":"3","key":"ref59","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"JJ Treanor","year":"1990","journal-title":"Journal of virology"},{"issue":"28","key":"ref60","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"AG Grandea 3rd","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.4049\/jimmunol.154.7.3162","article-title":"Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage","volume":"154","author":"A Meola","year":"1995","journal-title":"J Immunol"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/viro.1997.8632","article-title":"Protective immune responses induced by the immunization of mice with a recombinant bacteriophage displaying an epitope of the human respiratory syncytial virus","volume":"234","author":"N Bastien","year":"1997","journal-title":"Virology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T14:40:11Z","timestamp":1691678411000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126650"}},"subtitle":[],"editor":[{"given":"Sang-Moo","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126650","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}